RSS

haemophilia B

Pfizer and Spark Therapeutics have announced that the Phase III programme for the investigational haemophilia B gene therapy is to be initiated by Pfizer. more

News

A capsule has been developed that can treat people affected by the hereditary bleeding disorder haemophilia. more

News

The University College London Technology Fund has announced an investment of up to £1 million for the development of gene therapies more

News